12:00 AM
Mar 11, 2013
 |  BC Week In Review  |  Company News  |  Deals

API Co. Ltd., UMN Pharma, Yakult deal

Yakult, UMN and API signed a letter of intent to co-develop and commercialize biosimilars of several undisclosed...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >